FDA Inspection 1101775 — StemCyte, Inc
The FDA completed an inspection of StemCyte, Inc on July 31, 2019 in Baldwin Park, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 31, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Baldwin Park, CA (United States)